Cargando…
Survival of cancer patients with pre-existing heart disease
BACKGROUND: While cancer outcomes have improved over time, in Northern Ireland they continue to lag behind those of many other developed economies. The role of comorbid conditions has been suggested as a potential contributory factor in this but issues of data comparability across jurisdictions has...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351236/ https://www.ncbi.nlm.nih.gov/pubmed/35922767 http://dx.doi.org/10.1186/s12885-022-09944-z |
_version_ | 1784762399817990144 |
---|---|
author | O’Neill, Ciaran Donnelly, David W. Harbinson, Mark Kearney, Therese Fox, Colin R. Walls, Gerard Gavin, Anna |
author_facet | O’Neill, Ciaran Donnelly, David W. Harbinson, Mark Kearney, Therese Fox, Colin R. Walls, Gerard Gavin, Anna |
author_sort | O’Neill, Ciaran |
collection | PubMed |
description | BACKGROUND: While cancer outcomes have improved over time, in Northern Ireland they continue to lag behind those of many other developed economies. The role of comorbid conditions has been suggested as a potential contributory factor in this but issues of data comparability across jurisdictions has inhibited efforts to explore relationships. We use data from a single jurisdiction of the UK using data from - the Northern Ireland Cancer Registry (NICR), to examine the association between mortality (all-cause and cancer specific) and pre-existing cardiovascular diseases among patients with cancer. MATERIALS AND METHODS: All patients diagnosed with cancer (excluding non-melanoma skin cancer) between 2011 and 2014 were identified from Registry records. Those with a pre-existing diagnosis of cardiovascular diseases were identified by record linkage with patient hospital discharge data using ICD10 codes. Survival following diagnosis was examined using descriptive statistics and Cox proportional hazards regression analyses. Analyses examined all-cause mortality and cancer specific mortality for lung, colorectal, breast and prostate cancer. As well as cardiovascular diseases, regression models controlled for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities. RESULTS: Almost 35,000 incident cancer cases were diagnosed during the study period of which approximately 23% had a prior heart condition. The pan-cancer hazard ratio for death in the presence of pre-existing cardiovascular diseases was 1.28 (95% CI: 1.18-1.40). All-cause and cancer specific mortality was higher for patients with cardiovascular diseases across lung, female breast, prostate and colorectal cancer groups after controlling for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities. CONCLUSION: Pre-existing morbidity may restrict the treatment of cancer for many patients. In this cohort, cancer patients with pre-existing cardiovascular diseases had poorer outcomes than those without cardiovascular diseases. A high prevalence of cardiovascular diseases may contribute to poorer cancer outcomes at a national level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09944-z. |
format | Online Article Text |
id | pubmed-9351236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93512362022-08-05 Survival of cancer patients with pre-existing heart disease O’Neill, Ciaran Donnelly, David W. Harbinson, Mark Kearney, Therese Fox, Colin R. Walls, Gerard Gavin, Anna BMC Cancer Research BACKGROUND: While cancer outcomes have improved over time, in Northern Ireland they continue to lag behind those of many other developed economies. The role of comorbid conditions has been suggested as a potential contributory factor in this but issues of data comparability across jurisdictions has inhibited efforts to explore relationships. We use data from a single jurisdiction of the UK using data from - the Northern Ireland Cancer Registry (NICR), to examine the association between mortality (all-cause and cancer specific) and pre-existing cardiovascular diseases among patients with cancer. MATERIALS AND METHODS: All patients diagnosed with cancer (excluding non-melanoma skin cancer) between 2011 and 2014 were identified from Registry records. Those with a pre-existing diagnosis of cardiovascular diseases were identified by record linkage with patient hospital discharge data using ICD10 codes. Survival following diagnosis was examined using descriptive statistics and Cox proportional hazards regression analyses. Analyses examined all-cause mortality and cancer specific mortality for lung, colorectal, breast and prostate cancer. As well as cardiovascular diseases, regression models controlled for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities. RESULTS: Almost 35,000 incident cancer cases were diagnosed during the study period of which approximately 23% had a prior heart condition. The pan-cancer hazard ratio for death in the presence of pre-existing cardiovascular diseases was 1.28 (95% CI: 1.18-1.40). All-cause and cancer specific mortality was higher for patients with cardiovascular diseases across lung, female breast, prostate and colorectal cancer groups after controlling for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities. CONCLUSION: Pre-existing morbidity may restrict the treatment of cancer for many patients. In this cohort, cancer patients with pre-existing cardiovascular diseases had poorer outcomes than those without cardiovascular diseases. A high prevalence of cardiovascular diseases may contribute to poorer cancer outcomes at a national level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09944-z. BioMed Central 2022-08-03 /pmc/articles/PMC9351236/ /pubmed/35922767 http://dx.doi.org/10.1186/s12885-022-09944-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research O’Neill, Ciaran Donnelly, David W. Harbinson, Mark Kearney, Therese Fox, Colin R. Walls, Gerard Gavin, Anna Survival of cancer patients with pre-existing heart disease |
title | Survival of cancer patients with pre-existing heart disease |
title_full | Survival of cancer patients with pre-existing heart disease |
title_fullStr | Survival of cancer patients with pre-existing heart disease |
title_full_unstemmed | Survival of cancer patients with pre-existing heart disease |
title_short | Survival of cancer patients with pre-existing heart disease |
title_sort | survival of cancer patients with pre-existing heart disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351236/ https://www.ncbi.nlm.nih.gov/pubmed/35922767 http://dx.doi.org/10.1186/s12885-022-09944-z |
work_keys_str_mv | AT oneillciaran survivalofcancerpatientswithpreexistingheartdisease AT donnellydavidw survivalofcancerpatientswithpreexistingheartdisease AT harbinsonmark survivalofcancerpatientswithpreexistingheartdisease AT kearneytherese survivalofcancerpatientswithpreexistingheartdisease AT foxcolinr survivalofcancerpatientswithpreexistingheartdisease AT wallsgerard survivalofcancerpatientswithpreexistingheartdisease AT gavinanna survivalofcancerpatientswithpreexistingheartdisease |